Our Founder’s Story
Dr. Christina Drake invented the main material in NanoRAD as part of her quest to keep she and her family safe at the start of the COVID pandemic. She recalls walking through a grocery store in the early days of the lockdown and watching a store employee incorrectly use a disinfectant that she was highly allergic to. Christina has been asthmatic from a young age and developed an allergy to bleach. When one of her sons developed asthma, she was determined to limit the number of times he would have to seek medical care in contrast to her experience as an elementary-aged child living in a rural province in the Philippines with limited access to healthcare.
With a background in Material Science Engineering, Christina discovered a novel way to synthesize cerium oxide nanoparticles, resulting in the eradication of most of bacteria and viruses within two hours. Equally important to Christina as a mom, is that third-party toxicity results show this product is as safe as water. Christina set out to reimagine how the world disinfects, and NanoRAD goes far beyond that creating self-disinfecting surfaces.
Dr. Christina Drake
Founder & CEO
Christina earned a Ph.D. in Material Science Engineering from UCF. She has collaborated with many US government agencies and Department of Defense during the 10-year period she was with Lockheed Martin. Christina was the Faculty President at Florida Polytechnic prior to founding Kismet Technologies in 2019. She has secured more than 30 grants for funding in excess of $13 million. Christina has six patents and several more pending patents.
LinkedIn Email: cdrake@kismettechnologies.comDr. Christina Drake
Founder & CEO
Shari Dingle Costantini
Co-Founder & President
Shari was the founder and CEO of Avant Healthcare Professionals for 18 years. Avant and Shari received many awards and accolades for its sustained growth (38% CAGR for 18 years) including Inc 5000 seven times, Inc 250 Fastest Growing Private Companies regional award two times, EY Entrepreneur of the Year Florida 2017 and others. Shari has raised over $50M in angel, private equity and strategic investment. She exited Avant in July 2021. The company had revenues of $175M that year.
LinkedIn Email: scostantini@kismettechnologies.comShari Dingle Costantini
Co-Founder & President
Spence Lloyd
Chief Financial Officer
Spence has extensive experience in managing financial, administrative, legal, and operational functions for entrepreneurial, high-growth companies, both public and private. He and Shari were the CEO/CFO team at Avant during the years 2011 to 2019. Spence is a CPA with strong technical skills gained at Ernst & Young. His specialties include financial forecasting, workflow optimization, process improvement, change management, technology integration, contract negotiation, strategic planning, investor relations, raising private equity.
LinkedIn Email: slloyd@kismettechnologies.comSpencer D. Lloyd
Chief Financial Officer
Our Strategic Advisors
Patricia (Patty) Olinger, JM
Global Health Preparedness Expert | Wellness | Biorisk Management Expert | CEO at BEAMS LLC Consulting
Patty Olinger, a distinguished leader in public health, with a focus on wellness and public health preparedness. She currently holds the position of Founder and CEO at BEAMS LLC Consulting. By meticulously crafting targeted business development strategies and targets, Patty provides coaching, connections and consulting services that empowers organizations to expand their reach to achieve meaningful goals. Patty also serves on key Advisor Boards to pioneering biotech companies that are dedicated to delivering innovative solutions in the realms of health, wellness, and resilience programs.
Patricia (Patty) Olinger, JM
Strategic Advisor
Mark Montgomery
Strategic Advisor
Mark Montgomery, CEO of Bioplus Specialty Pharmacy, is a seasoned C-level healthcare executive boasting over 35 years of experience in senior leadership roles. His illustrious career began with his appointment as the CEO of Axium Healthcare in 2003. Demonstrating his strategic acumen, Mark successfully recapitalized the business through private equity in 2006, ultimately guiding the company to a lucrative acquisition by Kroger in 2012. This acquisition marked the inception of Kroger Specialty Pharmacy, which has since flourished into a thriving entity with an annual revenue surpassing $5 billion. In recognition of his entrepreneurial prowess, Mark was honored as an EY Entrepreneur of the Year in Florida in 2013.
In September 2018, Mark assumed the role of President at Bioplus Specialty Pharmacy. Over the course of four years, he secured private equity, ascended to the position of CEO, and orchestrated substantial growth, catapulting the company's annual revenue to over $2 billion by 2022. Under Mark's leadership, Bioplus was successfully acquired by Elevance, formerly known as Anthem Health, a Fortune 20 company. Mark's influence extends beyond the executive suite, as he has actively served on the boards of Axium, Panacea BioMatrix, Avant Healthcare Professionals, and Bioplus. Notably, he also contributed his expertise as a board member of PromptCare during his esteemed career.Mark Montgomery
Strategic Advisor
Mark Montgomery, JM
Strategic Advisor
Mark Montgomery, CEO of Bioplus Specialty Pharmacy, is a seasoned C-level healthcare executive boasting over 35 years of experience in senior leadership roles. His illustrious career began with his appointment as the CEO of Axium Healthcare in 2003. Demonstrating his strategic acumen, Mark successfully recapitalized the business through private equity in 2006, ultimately guiding the company to a lucrative acquisition by Kroger in 2012. This acquisition marked the inception of Kroger Specialty Pharmacy, which has since flourished into a thriving entity with an annual revenue surpassing $5 billion. In recognition of his entrepreneurial prowess, Mark was honored as an EY Entrepreneur of the Year in Florida in 2013.
In September 2018, Mark assumed the role of President at Bioplus Specialty Pharmacy. Over the course of four years, he secured private equity, ascended to the position of CEO, and orchestrated substantial growth, catapulting the company's annual revenue to over $2 billion by 2022. Under Mark's leadership, Bioplus was successfully acquired by Elevance, formerly known as Anthem Health, a Fortune 20 company. Mark's influence extends beyond the executive suite, as he has actively served on the boards of Axium, Panacea BioMatrix, Avant Healthcare Professionals, and Bioplus. Notably, he also contributed his expertise as a board member of PromptCare during his esteemed career.Mark Montgomery
Strategic Advisor & Board Member
Orlando Ashford
Orlando Ashford most recently served as president of Holland America Line. Orlando oversaw Holland America Line’s sales and marketing, revenue management, deployment and itinerary planning, public relations, hotel operations and strategy. Orlando was selected by Seattle Business Magazine for the 2019 Executive Excellence Award, honoring the best-of-the-best leaders in Washington state business and community. In 2017, Black Enterprise Magazine named Orlando to their 2017 list of the “Most Powerful Executives in Corporate America,” and in 2016 he was awarded a Travvy Award for “Most Innovative Executive, Mid-sized Cruise.” Orlando was also named to the “Directorship 100” of the National Association of Corporate Directors in 2013 and 2014, and since 2012 has been named to Savoy Magazine’s list of “Top 100 Most Influential Blacks in Corporate America.” He is a Purdue University School of Technology Distinguished Alumnus.
Orlando Ashford
Strategic Advisor
Dan Justin
Strategic Advisor
Dan Justin has over 30 years of experience engineering orthopedic medical implant systems. Mr. Justin was a Founder, Board Chair, and the Chief Executive Officer of Engage Surgical since its inception until it was acquired by Smith and Nephew Orthopedics in January 2022. He is the CEO of Nanovation Partners, and Chairman of Genesis New Ventures. He has led the development of over 110 other medical device systems used clinically world-wide including implant systems in the areas of knee, hip, and shoulder arthroplasty, sports medicine arthroscopy, spinal implants, foot and ankle implants, bone lengthening, and orthopedic trauma implants. He has published or presented over 40 national and international papers. He has a unique range of expertise including US FDA 510(k), PMA, and OUS regulatory clearance, manufacturing, quality control systems, sales, marketing, business development, and distribution processes. He has led large medical implant development teams and has extensive experience with advanced manufacturing techniques including metal 3-D printing and nano-texturing of implants, surgical guidance systems, and advanced materials. Mr. Justin has co-founded, co-led, and sold three start-up orthopedic companies, was CTO of IMDS/Coorstek Medical, and Engineering Manager of DePuy Mitek, a Johnson and Johnson Company. He has licensed technologies to or has been granted patents on devices sold by medical implant companies totaling over $1B in world-wide sales. He was Entrepreneur in Residence at the Florida Institute for the Commercialization of Public Research where he helped turn Florida-based research into start-up companies. He has a BSME and a MSME in Mechanical and Materials Science Engineering from the University of Central Florida. He has been granted over 170 issued U.S. Patents and is a U.S. Patent Agent. He serves on the Boards of privately held medical device companies and non-profit organizations.
Dan Justin
Strategic Advisor
Our Scientific Advisors
Dr. Sudipta Seal
UCF College of Engineering
Dr. Sudipta Seal is a world-renowned expert on rare earth/lanthanide metal oxide nanoparticles manufacturing for various biomedical applications. Dr. Seal is the Chair of the Materials Science & Engineering Department, a Pegasus Professor and University Distinguished Professor.
Dr. Sudipta Seal
UCF College of Engineering
Dr. Griffith Parks
UCF College of Medicine
Dr. Griffith Parks is an internationally recognized expert in the molecular and cellular biology of RNA viruses, with more than 30 years of experience researching human pathogenic viruses such as poliovirus, influenza virus, parainfluenza virus, and Zika virus. He is Associate Dean for Research in the College of Medicine at UCF, Director of the Biomedical Sciences Graduate Program, Director of the Burnett School of Biomedical Sciences and Professor of Medicine.
Dr. Griffith Parks
UCF College of Medicine
Dr. Melanie Coathup
UCF College of Medicine
Dr. Melanie Coathup is Director of the Biionix Cluster at UCF, and her research focuses on translational innovation and the development of therapies and technologies that deliver improved patient care. Her research has led to a novel implant design being used in patients worldwide, and a novel biostimulative scaffold developed for accelerated bone repair, now marketed by Baxter Healthcare, and used in spinal fusion surgery.
Dr. Melanie Coathup
UCF College of Medicine
The Kismet WHY
Our Vision
To be the leaders in delivering innovative material technologies that help people achieve healthier, safer lives worldwide with minimal impact to the planet.
Our Mission
To create new material technologies that stop the spread of infections to improve a person’s quality of life and overall health.
Our Core Values
To act with integrity.
To treat people with dignity.
To deliver technology solutions that do good for communities and the world.